Patents by Inventor Marc De Block

Marc De Block has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060185038
    Abstract: Methods and means are provided to increase the tolerance of plants to abiotic stress or adverse growing conditions, including drought, high light intensities, high temperatures, nutrient limitations and the like by reducing the activity of endogenous PARG proteins in plants.
    Type: Application
    Filed: April 9, 2004
    Publication date: August 17, 2006
    Applicant: Bayer BioScience N.V.
    Inventor: Marc De Block
  • Patent number: 7084320
    Abstract: The present invention provides methods and means for determining parent inbred plant lines with good combining ability, for determining good combinations of parent inbred plant lines capable of yielding hybrid lines with high heterosis, and further for determining the agronomical performance of different plant lines, which can be performed in vitro by determining the electron flow in the mitochondria under control and stress conditions.
    Type: Grant
    Filed: February 19, 2002
    Date of Patent: August 1, 2006
    Assignee: Bayer Bioscience N.V.
    Inventor: Marc De Block
  • Publication number: 20050014268
    Abstract: The invention concerns a process for producing transgenic plant cells, which comprises: contacting a culture of plant cells with an inhibitor of poly-(ADP-ribose) polymerase, prior to transformation, for a period of time sufficient to reduce the response of the cultured cells to stress and to reduce their metabolism. The untransformed cells are then contacted with foreign DNA comprising at least one gene of interest under conditions in which the foreign DNA is taken up by the untransformed cells and the gene of interest is stably integrated in the nuclear genome of the untransformed cells to produce the transgenic cells. The transgenic plant cells are recovered from the culture.
    Type: Application
    Filed: May 21, 2004
    Publication date: January 20, 2005
    Inventor: Marc De Block
  • Publication number: 20040128704
    Abstract: The invention provides for the use of isolated polynucleotides encoding maize poly (ADP-ribose) polymerase (PARP) proteins to produce eukaryotic cells and organisms, particularly plant cells and plants, with modified programmed cell death. Eukaryotic cells and organisms particularly plant cells and plants, are provided wherein either in at least part of the cells, preferably selected cells, the programmed cell death (PCD) is provoked, or wherein, on the contrary, PCD of the cells or of at least part of the cells in an organism is inhibited, by modulation of the level or activity or PARP proteins in those cells.
    Type: Application
    Filed: November 12, 2003
    Publication date: July 1, 2004
    Applicant: BAYER BIOSCIENCE
    Inventors: Elena Babiychuk, Sergei Kushnir, Marc De Block
  • Publication number: 20040093631
    Abstract: The present invention provides methods and means for determining parent inbred plant lines with good combining ability, for determining good combinations of parent inbred plant lines capable of yielding hybrid lines with high heterosis, and further for determining the agronomical performance of different plant lines, which can be performed in vitro by determining the electron flow in the mitochondria under control and stress conditions.
    Type: Application
    Filed: August 18, 2003
    Publication date: May 13, 2004
    Inventor: Marc De Block
  • Patent number: 6693185
    Abstract: The invention provides for the use of isolated polynucleotides encoding maize poly (ADP-ribose) polymerase (PARP) proteins to produce eukaryotic cells and organisms, particularly plant cells and plants, with modified programmed cell death. Eukaryotic cells and organisms particularly plant cells and plants, are provided wherein either in at least part of the cells, preferably selected cells, the programmed cell death (PCD) is provoked, or wherein, on the contrary, PCD of the cells or of at least part of the cells in an organism is inhibited, by modulation of the level or activity or PARP proteins in those cells.
    Type: Grant
    Filed: July 17, 1998
    Date of Patent: February 17, 2004
    Assignee: Bayer Bioscience N.V.
    Inventors: Elena Babiychuk, Sergei Kushnir, Marc De Block
  • Publication number: 20010011381
    Abstract: The invention concerns a process for producing transgenic eucaryotic cells, particularly plants, which comprises: contacting a culture of untransformed cells with an inhibitor of poly-(ADP-ribose) polymerase for a period of time sufficient to reduce the response of the cultured cells to stress and to reduce their metabolism. The untransformed cells are then contacted with foreign DNA comprising at least one gene of interest under conditions in which the foreign DNA is taken up by the untransformed cells and the gene of interest is stably integrated in the nuclear genome of the untransformed cells to produce the transgenic cells. Optionally, the transgenic cells are recovered from the culture. Preferably, the inhibitor is niacinamide, preferably at a concentration of about 200 mg/l to 500 mg/l and the untransformed cells are cultured in a medium containing the inhibitor for a period of time of approximately 3 to 14 days prior to the contacting with the foreign DNA.
    Type: Application
    Filed: July 17, 1998
    Publication date: August 2, 2001
    Inventors: ELENA BABIYCHUK, SERGEI KUSHNIR, MARC DE BLOCK
  • Patent number: 6074876
    Abstract: The invention concerns a process for producing transgenic plant cells, which comprises: contacting a culture of plant cells with an inhibitor of poly-(ADP-ribose) polymerase, prior to transformation, for a period of time sufficient to reduce the response of the cultured cells to stress and to reduce their metabolism. The untransformed cells are then contacted with foreign DNA comprising at least one gene of interest under conditions in which the foreign DNA is taken up by the untransformed cells and the gene of interest is stably integrated in the nuclear genome of the untransformed cells to produce the transgenic cells. The transgenic plant cells are recovered from the culture.
    Type: Grant
    Filed: May 15, 1997
    Date of Patent: June 13, 2000
    Assignee: Plant Genetic Systems, N.V.
    Inventor: Marc De Block
  • Patent number: 5646024
    Abstract: The invention relates to a DNA fragment containing a determined gene, the expression of which inhibits the antibiotic and herbicidal effects of Bialaphos and related products.It also relates to recombinant vectors, containing such DNA fragment, which enable this protective gene to be introduced and expressed into cells and plant cells.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: July 8, 1997
    Assignee: Plant Genetic Systems, N.V.
    Inventors: Jan Leemans, Johan Botterman, Marc De Block, Charles Thompson, Rao Mouva
  • Patent number: 5561236
    Abstract: The invention relates to a DNA fragment containing a determined gene, the expression of which inhibits the antibiotic and herbicidal effects of Bialaphos and related products.It also relates to recombinant vectors, containing such DNA fragment, which enable this protective gene to be introduced and expressed into cells and plant cells.
    Type: Grant
    Filed: May 17, 1990
    Date of Patent: October 1, 1996
    Assignees: Plant Genetic Systems, Biogen, Inc.
    Inventors: Jan Leemans, Johan Botterman, Marc De Block, Charles Thompson, Rao Mouva